Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Stephens

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Biochemical and Biophysical Research Communications|August 6, 1973
Calf thymus GMP reductase: control by XMPR W Stephens, V K Whittaker
European Journal of Biochemistry|March 1, 1984
Novel properties of human monocyte plasminogen activatorR W Stephens, J P Golder
European Journal of Biochemistry|November 15, 1983
Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activatorsJ P Golder, R W Stephens
Advances in Cancer Research|January 1, 1991
Directed plasminogen activation at the surface of normal and malignant cellsJ Pöllänen, R W Stephens, A Vaheri
Annals of the Rheumatic Diseases|September 19, 2000
Marker of erosive progression in RAO Slot, N Brünner, R W Stephens
International Journal of Cancer|February 1, 1993
Persistence of plasmin-mediated pro-urokinase activation on the surface of human monocytoid leukemia cells in vitroH Tapiovaara, R W Stephens, A Vaheri
The Medical Journal of Australia|March 8, 1975
Letter: The inhibition of synovial fluid polysaccharidases by gold sodium thiomalateP Ghosh, R W Stephens, T K Taylor
Biochimica Et Biophysica Acta|July 14, 1975
The characterisation and function of the polysaccharidases of human synovial fluid in rheumatoid and osteoarthritisR W Stephens, P Ghosh, T K Taylor
Medical Hypotheses|July 1, 1979
The pathogenesis of osteoarthrosisR W Stephens, P Ghosh, T K Taylor
Breast Cancer Research and Treatment|March 5, 1999
The urokinase plasminogen activator system as a target for prognostic studies in breast cancerR W Stephens, N Brünner, F Jänicke, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Biochemical and Biophysical Research Communications|August 6, 1973
Calf thymus GMP reductase: control by XMPR W Stephens, V K Whittaker
European Journal of Biochemistry|March 1, 1984
Novel properties of human monocyte plasminogen activatorR W Stephens, J P Golder
European Journal of Biochemistry|November 15, 1983
Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activatorsJ P Golder, R W Stephens
Advances in Cancer Research|January 1, 1991
Directed plasminogen activation at the surface of normal and malignant cellsJ Pöllänen, R W Stephens, A Vaheri
Annals of the Rheumatic Diseases|September 19, 2000
Marker of erosive progression in RAO Slot, N Brünner, R W Stephens
International Journal of Cancer|February 1, 1993
Persistence of plasmin-mediated pro-urokinase activation on the surface of human monocytoid leukemia cells in vitroH Tapiovaara, R W Stephens, A Vaheri
The Medical Journal of Australia|March 8, 1975
Letter: The inhibition of synovial fluid polysaccharidases by gold sodium thiomalateP Ghosh, R W Stephens, T K Taylor
Biochimica Et Biophysica Acta|July 14, 1975
The characterisation and function of the polysaccharidases of human synovial fluid in rheumatoid and osteoarthritisR W Stephens, P Ghosh, T K Taylor
Medical Hypotheses|July 1, 1979
The pathogenesis of osteoarthrosisR W Stephens, P Ghosh, T K Taylor
Breast Cancer Research and Treatment|March 5, 1999
The urokinase plasminogen activator system as a target for prognostic studies in breast cancerR W Stephens, N Brünner, F Jänicke, et al.
Pageof 10